Arvee Laboratories (India) Ltd

Stage 2 · Advancing · week 4Setup 6.4 ★ FairEven -0.1

As of 16 Oct 2026, Arvee Laboratories (India) is in Stage 2 — advancing, the uptrend phase, in week 4 (since 23 Sep 2026). It closed at ₹226, 22.2% below its 52-week high and above its 200-day average, which is rising. In Materials, 33.6% of stocks are in Stage 2.

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. More about the company

₹226.2
+0.13% today
₹249 Cr · Micro cap
Market Neutral — FadingMaterials 33.6% in Stage 2-2.9 pts / 20dSpecialty Chemicals 43.8%-3.4 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

6.4 ★ Fair

Momentum

Steady

Edge

Even -0.1

Setup-score rank among Stage 2 peers: #16 of 39 in Specialty Chemicals · #48 of 153 in Materials

Is ARVEE early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-22.2%
₹133.9 lo₹290.8 hi
22.2% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 4
1w13w26w
Week 4 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
32.3%
200 DMA: ₹171 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.64x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +8.5% vs MA50 +14.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+34.4%
3M
+43.2%
6M
+41.2%
YTD
-22.2%
1Y
+35.3%
Sector
Materials
↓ Peaking
Stage 2%
33.6%
20d Δ
-2.9pp
1M return
-1.6%
3M return
-2.6%
Sector Stage-2 % · last 20 days
This stock ranks #53 of 151 Stage 2 stocks in Materials by RS.
Industry
Specialty Chemicals
↓ Peaking
Stage 2%
43.8%
20d Δ
-3.4pp
1M return
+0.5%
3M return
+9.2%
Industry Stage-2 % · last 20 days
Ranks #13 of 38 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-19 → 2026-10-16
S2 20w
S3 16w
S4 19w
S3 14w
2023-07-192026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 1w → S2 5w → S3 2w → S4 3w → S3 1w → S2 20w → S3 6w → S2 12w → S3 16w → S2 2w → S3 1w → S4 6w → S1 2w → S4 19w → S1 6w → S2 7w → S3 14w → S2 11w → S3 4w → S4 7w → S1 11w → S4 5w → S1 4w → S2 3w current
Total tracked: 167 weeks across 25 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-09-23
5 appearances in last 60 days. First seen: 2024-04-12.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 4 · Vol 0.64x
2026-10-15S2
Wk 4 · Vol 2.09x
2026-10-14S2
Wk 3 · Vol 1.17x
2026-10-13S2
Wk 3 · Vol 0.19x
2026-10-12S2
Wk 3 · Vol 0.34x
2026-10-09S2
Wk 3 · Vol 0.20x
2026-10-08S2
Wk 3 · Vol 0.25x
2026-10-07S2
Wk 2 · Vol 0.30x
2026-10-06S2
Wk 2 · Vol 0.48x
2026-10-05S2
Wk 2 · Vol 0.51x
2026-10-01S2
Wk 2 · Vol 0.43x
2026-09-30S2
Wk 2 · Vol 0.33x
Sector Peers — Stage 2All →
OCCLLTD
wk 17 · -16.3% from hi
9.0
MUKANDLTD
wk 21 · -7.5% from hi
8.9
SUNFLAG
wk 3 · -9.3% from hi
8.8
CUBEXTUB
wk 2 · 0.0% from hi
8.7
NRL
wk 17 · 0.0% from hi
8.6
Moving averages & range
50 DMA
₹189.4
200 DMA
₹171
52W High
₹290.8
52W Low
₹133.9
5D Low
₹196.5
Resistance levels (recent highs)
20d High
₹242.2
60d High
₹242.2
120d High
₹242.2
250d High
₹290.8
Next resistance
+7.1%
to 20d High
Ask the Market AI about ARVEEAsk →
P/E (TTM)
85.1
Forward —
Earnings Growth (YoY)
+1085.7%
Revenue +9.8%
About this companyMaterials· Specialty Chemicals

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.